thalidomide has been researched along with dinoprostone in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Lacosta Nicolás, JL; Martínez Iñiguez, JC | 1 |
| Dalgleish, AG; Dransfield, I; Guckian, M; Hay, P | 1 |
| Cunha, FQ; Ferreira, SH | 1 |
| Chen, RS; Haley, M; Muller, GW; Payvandi, F; Schafer, PH; Stirling, DI; Wu, L; Zhang, LH | 1 |
| Hayashi, H; Kobayashi, M; Naito, K; Nakamura, S; Ohnishi, K; Sahara, N; Shibata, K; Shigeno, K; Shinjo, K | 1 |
| Chen, Y; Kiatsimkul, P; Nugent, K; Raj, R | 1 |
2 review(s) available for thalidomide and dinoprostone
| Article | Year |
|---|---|
[Treatment of recurrent aphthous stomatitis. A bibliographic review].
Topics: Adrenal Cortex Hormones; Adult; Calcium Phosphates; Dinoprostone; Female; Glycopeptides; Humans; Immunologic Factors; Immunosuppressive Agents; Interferons; Male; Oxytocics; Pentoxifylline; Phosphodiesterase Inhibitors; Recurrence; Stomatitis, Aphthous; Thalidomide | 1998 |
Peripheral hyperalgesic cytokines.
Topics: Analgesics; Animals; Bradykinin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytokines; Dexamethasone; Dinoprostone; Drug Evaluation, Preclinical; Hot Temperature; Humans; Hyperalgesia; Interleukin-1; Interleukin-1beta; Interleukins; Isoenzymes; Membrane Proteins; Nerve Growth Factor; Nociceptors; Pain Measurement; Peptide Fragments; Prostaglandin-Endoperoxide Synthases; Rats; Thalidomide; Tumor Necrosis Factor-alpha | 2003 |
6 other study(ies) available for thalidomide and dinoprostone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Thalidomide analogue CC-3052 reduces HIV+ neutrophil apoptosis in vitro.
Topics: Adjuvants, Immunologic; Adult; Apoptosis; Cyclic AMP; Dinoprostone; Drug Synergism; Female; HIV Infections; Humans; In Vitro Techniques; Male; Middle Aged; Neutrophils; Thalidomide; Tumor Necrosis Factor-alpha | 2000 |
Immunomodulatory drugs inhibit expression of cyclooxygenase-2 from TNF-alpha, IL-1beta, and LPS-stimulated human PBMC in a partially IL-10-dependent manner.
Topics: Blotting, Northern; Blotting, Western; Cyclooxygenase 2; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Humans; Immunologic Factors; Interleukin-10; Isoenzymes; Lenalidomide; Leukocytes, Mononuclear; Lipopolysaccharides; Lymphocyte Activation; Lymphotoxin-alpha; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; RNA; Thalidomide; Tumor Necrosis Factor-alpha | 2004 |
Etodolac induces apoptosis and inhibits cell adhesion to bone marrow stromal cells in human myeloma cells.
Topics: Apoptosis; Bone Marrow Cells; Caspase 3; Caspases; Cell Adhesion; Cell Line; Cell Proliferation; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Etodolac; Humans; Membrane Potentials; Multiple Myeloma; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stereoisomerism; Stromal Cells; Thalidomide | 2006 |
Lenalidomide-induced interstitial lung disease.
Topics: Aged; Antineoplastic Agents; Combined Modality Therapy; Diagnosis, Differential; Dinoprostone; Female; Humans; Lenalidomide; Lung; Lung Diseases, Interstitial; Multiple Myeloma; Thalidomide; Treatment Outcome | 2010 |